MedTrace Logo

Early Predictors of Necrotizing Enterocolitis in Neonates

NCT03210831 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2025-06-29

No results posted yet for this study

Summary

The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.

Conditions

  • Necrotizing Enterocolitis

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • Oluyinka Olutoye, MD, PhD · Nationwide Children's Hospital

Eligibility

Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03210831 on ClinicalTrials.gov